首都医科大学学报 ›› 2023, Vol. 44 ›› Issue (3): 387-392.doi: 10.3969/j.issn.1006-7795.2023.03.005
韦莹,王广*
收稿日期:
2023-03-01
出版日期:
2023-06-21
发布日期:
2023-06-08
通讯作者:
王广
E-mail: wangguang@bjcyh.com
基金资助:
Wei Ying, Wang Guang*
Received:
2023-03-01
Online:
2023-06-21
Published:
2023-06-08
Supported by:
摘要: 目的 本研究拟探讨糖化血红蛋白指数(hemoglobin glycation index,HGI)与颈动脉斑块之间的关系。 方法 本研究纳入2016年4月至2021年8月在首都医科大学附属北京朝阳医院进行健康体检的成人,测量糖化血红蛋白(hemoglobin A1c,HbA1c)与空腹血糖,计算HGI,并将HGI根据三分位数分成3组(Q1,Q2,Q3)。使用Logistic 回归分析影响颈动脉斑块的独立危险因素。结果 本研究共纳入1 106位参与者。HGI高分位(Q3)组中45岁以上人数明显增多。同时,Q3组呈现更明显的代谢异常,表现为:高血压、高脂血症、糖尿病所占人数的比例更多,总胆固醇、三酰甘油、低密度脂蛋白胆固醇、HbA1c浓度最高(P<0.05)。Q3组人群中具有颈动脉斑块的比例也最高(Q1∶Q2∶Q3为23.8% vs 23.9% vs 39.6%, P<0.001)。在校正了年龄、性别、体质量指数、高血压、高脂血症、糖尿病、估算的肾小球滤过率以及尿酸后,HGI中分位(Q2)组具有颈动脉斑块的风险是HGI低分位(Q1)组的1.47倍(OR=1.47,95%CI:0.98~2.20,P=0.06),HGI高分位组具有颈动脉斑块的风险是HGI低分位组的1.66倍(OR=1.66,95%CI: 1.14~2.43,P=0.008)。结论 HGI升高与多种心血管代谢的危险因素相关,是颈动脉斑块的独立危险因素。HGI检测有望用于临床上心血管代谢性疾病的个性化风险评估和预测。
中图分类号:
韦莹, 王广. 糖化血红蛋白指数升高增加颈动脉斑块风险[J]. 首都医科大学学报, 2023, 44(3): 387-392.
Wei Ying, Wang Guang. Higher hemoglobin glycation index is associated with higher risk of carotid plaques[J]. Journal of Capital Medical University, 2023, 44(3): 387-392.
[1]American Diabetes Association Professional Practice Committee. 2. Classification and diagnosis of diabetes: standards of medical care in diabetes-2022[J]. Diabetes Care, 2022, 45(Suppl 1): S17-S38. [2]Nayak A U, Singh B M, Dunmore S J. Potential clinical error arising from use of HbA1c in diabetes: effects of the glycation gap[J]. Endocr Rev, 2019, 40(4): 988-999. [3]Hempe J M, Liu S, Myers L, et al. The hemoglobin glycation index identifies subpopulations with harms or benefits from intensive treatment in the ACCORD trial[J]. Diabetes Care, 2015, 38(6): 1067-1074. [4]Soros A A, Chalew S A, McCarter R J, et al. Hemoglobin glycation index: a robust measure of hemoglobin A1c bias in pediatric type 1 diabetes patients[J]. Pediatr Diabetes, 2010, 11(7): 455-461. [5]Marini M A, Fiorentino T V, Succurro E, et al. Association between hemoglobin glycation index with insulin resistance and carotid atherosclerosis in non-diabetic individuals[J]. PLoS One, 2017, 12(4): e0175547. [6]Yoo J H, Kang Y M, Cho Y K, et al. The haemoglobin glycation index is associated with nonalcoholic fatty liver disease in healthy subjects[J]. Clin Endocrinol (Oxf), 2019, 91(2): 271-277. [7]Fiorentino T V, Marini M A, Succurro E, et al. Association between hemoglobin glycation index and hepatic steatosis in non-diabetic individuals[J]. Diabetes Res Clin Pract, 2017, 134: 53-61. [8]Wei Y, Wu Z Y, Wang Y, et al. Interaction of sex and diabetes on the association between hemoglobin glycation index, hemoglobin A1c and serum uric acid[J]. Diabetol Metab Syndr, 2022, 14(1): 185. [9]McCarter R J, Hempe J M, Gomez R, et al. Biological variation in HbA1c predicts risk of retinopathy and nephropathy in type 1 diabetes[J]. Diabetes Care, 2004, 27(6): 1259-1264. [10]Ahn C H, Min S H, Lee D H, et al. Hemoglobin glycation index is associated with cardiovascular diseases in people with impaired glucose metabolism[J]. J Clin Endocrinol Metab, 2017, 102(8): 2905-2913. [11]Cheng P C, Hsu S R, Cheng Y C, et al. Relationship between hemoglobin glycation index and extent of coronary heart disease in individuals with type 2 diabetes mellitus: a cross-sectional study[J]. Peer J, 2017, 5: e3875. [12]Rhee E J, Cho J H, Kwon H, et al. Association between coronary artery calcification and the hemoglobin glycation index: the kangbuk samsung health study[J]. J Clin Endocrinol Metab, 2017, 102(12): 4634-4641. [13]World Health Organization. Hypertension[EB/OL]. (2021-08-25)[2022-12-01]. https://www.who.int/news-room/fact-sheets/detail/hypertension. [14]中国血脂管理指南修订联合专家委员会. 中国血脂管理指南(2023年)[J]. 中华心血管病杂志, 2023, 51(3): 221-255. [15]Levey A S, Stevens L A, Schmid C H, et al. A new equation to estimate glomerular filtration rate[J]. Ann Intern Med, 2009, 150(9): 604-612. [16]Ebrahim S, Papacosta O, Whincup P, et al. Carotid plaque, intima media thickness, cardiovascular risk factors, and prevalent cardiovascular disease in men and women: the British Regional Heart Study[J]. Stroke, 1999, 30(4): 841-850. [17]Li F R, Yang H L, Zhou R, et al. Diabetes duration and glycaemic control as predictors of cardiovascular disease and mortality[J]. Diabetes Obes Metab, 2021, 23(6): 1361-1370. [18]OLeary D H, Polak J F, Kronmal R A, et al. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults[J]. N Engl J Med, 1999, 340(1): 14-22. [19]Felipe D L, Hempe J M, Liu S Q, et al. Skin intrinsic fluorescence is associated with hemoglobin A1c and hemoglobin glycation index but not mean blood glucose in children with type 1 diabetes[J]. Diabetes Care, 2011, 34(8): 1816-1820. [20]Goldin A, Beckman J A, Schmidt A M, et al. Advanced glycation end products: sparking the development of diabetic vascular injury[J]. Circulation, 2006, 114(6): 597-605. [21]Uribarri J, Cai W J, Ramdas M, et al. Restriction of advanced glycation end products improves insulin resistance in human type 2 diabetes: potential role of AGER1 and SIRT1[J]. Diabetes Care, 2011, 34(7): 1610-1616. [22]Howard G, OLeary D H, Zaccaro D, et al. Insulin sensitivity and atherosclerosis. The Insulin Resistance Atherosclerosis Study (IRAS) Investigators[J]. Circulation, 1996, 93(10): 1809-1817. [23]Cipollone F, Iezzi A, Fazia M, et al. The receptor RAGE as a progression factor amplifying arachidonate-dependent inflammatory and proteolytic response in human atherosclerotic plaques[J]. Circulation, 2003, 108(9): 1070-1077. [24]Song P G, Fang Z, Wang H Y, et al. Global and regional prevalence, burden, and risk factors for carotid atherosclerosis: a systematic review, meta-analysis, and modelling study[J]. Lancet Glob Health, 2020, 8(5): e721-e729. |
[1] | 马薇, 周一帆, 姜慧敏, 卫慧敏, 周陈, 吉训明. 脑静脉窦血栓形成动物模型研究进展[J]. 首都医科大学学报, 2023, 44(5): 704-714. |
[2] | 冯丹, 李娜, 侯东燕. 血清残粒脂蛋白胆固醇浓度与急性心肌梗死相关性分析[J]. 首都医科大学学报, 2023, 44(5): 872-876. |
[3] | 周 力, 朱 超, 王福财, 崔贺贺, 刘青波, 赵慧强, 陈 晖. 药物涂层球囊在急性心肌梗死直接经皮冠状动脉介入术中的应用[J]. 首都医科大学学报, 2023, 44(4): 669-675. |
[4] | 高霞, 延晋, 姚志, 王广. 三酰甘油葡萄糖指数与新诊断的冠状动脉粥样硬化性心脏病患者冠状动脉病变程度的相关性[J]. 首都医科大学学报, 2023, 44(3): 381-386. |
[5] | 李杰, 张隽, 王晶, 华琳, 张黎明. 嗜酸性肉芽肿性多血管炎肾受累的临床分析[J]. 首都医科大学学报, 2023, 44(3): 494-500. |
[6] | 罗晓萌, 江雪, 杜凤和, 郭彩霞. 急性冠状动脉综合征患者血浆sRAGE、IFN-γ浓度及其与冠状动脉病变严重程度的关系[J]. 首都医科大学学报, 2023, 44(2): 272-279. |
[7] | 徐建可, 刘宁, 韩苗, 张洪阳, 韩新生. 缺血性脑卒中患者颈动脉斑块性质与非高密度脂蛋白胆固醇浓度的相关性[J]. 首都医科大学学报, 2023, 44(1): 49-53. |
[8] | 王荣荣, 田俊萍. 急性冠脉综合征患者血清钙与心血管预后的关系[J]. 首都医科大学学报, 2023, 44(1): 154-160. |
[9] | 赵继宗. 我国脑心血管共患疾病现状与临床研究[J]. 首都医科大学学报, 2022, 43(5): 671-673. |
[10] | 冯莉, 杨佳雪, 李新, 贾长琪, 蒋晨曦. hERG1a突变H70R对hERG1a单源四聚体和hERG1a/hERG1b二源四聚体通道功能的影响[J]. 首都医科大学学报, 2022, 43(5): 747-753. |
[11] | 马艺欣, 张仲迎, 佀思聪, 罗鸿宇, 赵欢, 杨伟. 2型糖尿病患者新型脂肪因子血清内脏脂肪素和内脏脂肪特异性丝氨酸蛋白酶抑制因子的表达水平与左心室肥厚的关系[J]. 首都医科大学学报, 2022, 43(5): 767-773. |
[12] | 陈璐, 郭新颖, 刘建, 杜凤和, 郭彩霞. 冠状动脉粥样硬化性心脏病患者可溶性高级糖基化终末产物受体与肾功能的相关性分析[J]. 首都医科大学学报, 2022, 43(2): 167-172. |
[13] | 苏文, 李虹伟, 陈晖, 李卫萍. 急性心肌梗死患者D二聚体质量浓度与远期预后的关系[J]. 首都医科大学学报, 2022, 43(2): 173-177. |
[14] | 王茜, 张家坤, 刘青, 孙琳, 李晶洁. M2巨噬细胞对新生乳鼠受损心脏组织的再生和修复机制[J]. 首都医科大学学报, 2022, 43(2): 178-186. |
[15] | 任春琦, 孔羽, 伏圣高, 朱正炎, 杜昕. 中青年钙化性主动脉瓣疾病的特征及危险因素分析[J]. 首都医科大学学报, 2022, 43(2): 187-191. |
阅读次数 | ||||||||||||||||||||||||||||||||||||||||||||||||||
全文 72
|
|
|||||||||||||||||||||||||||||||||||||||||||||||||
摘要 226
|
|
|||||||||||||||||||||||||||||||||||||||||||||||||